v3.24.1.1.u2
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Feb. 29, 2024
Feb. 28, 2023
Feb. 28, 2022
Cash Flows From Operating Activities      
Net Income (Loss) $ (4,171,883) $ (5,680,778) $ (341,697)
Less: Net Income (Loss) from discontinued operations, net of tax 703,834 (192,422) 158,020
Net Loss from continuing operations (4,875,717) (5,488,356) (499,717)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 887,299 765,263 740,175
Provision for obsolete inventory 188,786 732,499 384,473
Provision for loss (recovery) on accounts and notes receivable (402,117) (277,000) 0
Asset impairment and store closure losses 0 84,183 0
Loss (gain) on sale or disposal of property and equipment (37,002) 11,958 (159,129)
Expense recorded for stock compensation 437,829 651,016 1,073,115
Deferred income taxes 0 722,163 (267,576)
Changes in operating assets and liabilities:      
Accounts receivable 227,053 82,050 46,311
Refundable income taxes 298,916 391,643 37,999
Inventories (878,771) (70,069) (581,433)
Other current assets (101,466) (7,246) (122,647)
Accounts payable 974,769 661,111 200,557
Accrued liabilities 999,483 (1,163,216) 1,332,993
Contract liabilities (114,767) 5,384 26,321
Net cash (used in) provided by operating activities of continuing operations (2,395,705) (2,898,617) 2,211,442
Net cash provided by (used in) operating activities of discontinued operations (39,242) 796,126 646,712
Net cash (used in) provided by operating activities (2,434,947) (2,102,491) 2,858,154
Cash Flows from Investing Activities      
Addition to notes receivable (135,955) (64,621) 0
Proceeds received on notes receivable 163,989 62,411 109,809
Proceeds from insurance recovery 0 0 206,336
Proceeds from the sale or distribution of assets 112,131 27,289 2,693
Purchases of property and equipment (3,017,473) (1,000,015) (941,327)
Other 9,463 10,000 (10,000)
Net cash used in investing activities of continuing operations (2,867,845) (964,936) (632,489)
Net cash provided by investing activities of discontinued operations 1,417,738 197,121 27,491
Net cash used in investing activities (1,450,107) (767,815) (604,998)
Cash Flows from Financing Activities      
Repurchase of common stock through net settlement of restricted stock units 0 0 (237,785)
Proceeds from line of credit 1,250,000 0 0
Dividends paid and redemption of outstanding preferred stock purchase rights 0 0 (61,276)
Net cash (used in) provided by financing activities of discontinued operations 0 0 0
Net cash provided by (used in) financing activities 1,250,000 0 (299,061)
Net Increase (Decrease) in Cash and Cash Equivalents (2,635,054) (2,870,306) 1,954,095
Cash and Cash Equivalents, Beginning of Year 4,717,068 7,587,374 5,633,279
Cash and Cash Equivalents, End of Year $ 2,082,014 $ 4,717,068 $ 7,587,374

Source